Analytical Data
-
Gene name
RPS6
- Application
-
Alternative Names
Phosphoprotein NP33 （Small ribosomal subunit protein eS6）
-
Species
Human
-
Source
E. coli
-
Tag
N- His-GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P62753
-
Expression Region
35-229aa
-
Molecular Weight
53.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPS6, or Ribosomal Protein S6, is a crucial component of the ribosome that plays a significant role in protein synthesis and cellular growth. It is a key player in the regulation of translation and is heavily involved in the response to growth factors and hormones. Dysregulation of RPS6 has been implicated in various diseases, including cancer, as it is associated with the signaling pathways of mTOR (mammalian Target of Rapamycin), which regulates cell growth and metabolism. The study of RPS6 recombinant proteins has gained momentum in recent years due to the potential therapeutic implications of targeting RPS6 in disease contexts. By producing RPS6 as a recombinant protein, researchers can investigate its structural and functional properties, enabling a deeper understanding of its role in translation regulation. Furthermore, studying RPS6 in its recombinant form allows for the exploration of post-translational modifications and protein interactions that are critical for its activity. This research holds promise for developing novel therapeutic strategies aimed at modulating protein synthesis in disease states, particularly in cancers where RPS6 activity is often aberrant. Through these studies, scientists hope to delineate the specific functions of RPS6 and its potential as a biomarker or therapeutic target in disease management.
